SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-029721
Filing Date
2023-08-21
Accepted
2023-08-21 17:24:52
Documents
51
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1126442
2 ex31-1.htm EX-31.1 13771
3 ex31-2.htm EX-31.2 13764
4 ex32-1.htm EX-32.1 7987
  Complete submission text file 0001493152-23-029721.txt   4594482

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tsoi-20230630.xsd EX-101.SCH 27860
6 XBRL CALCULATION FILE tsoi-20230630_cal.xml EX-101.CAL 54864
7 XBRL DEFINITION FILE tsoi-20230630_def.xml EX-101.DEF 119326
8 XBRL LABEL FILE tsoi-20230630_lab.xml EX-101.LAB 272705
9 XBRL PRESENTATION FILE tsoi-20230630_pre.xml EX-101.PRE 212461
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 544038
Mailing Address 701 WILD ROSE LANE ELK CITY ID 83525
Business Address 701 WILD ROSE LANE ELK CITY ID 83525 (760) 295-7208
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (Filer) CIK: 0001419051 (see all company filings)

IRS No.: 451226465 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54554 | Film No.: 231190088
SIC: 3841 Surgical & Medical Instruments & Apparatus